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Abstract 
 
Drugs do not act solely by canonical ligand–receptor binding interactions. Amphiphilic drugs partition 
into membranes, thereby perturbing bulk lipid bilayer properties and possibly altering the function of 
membrane proteins. Distinguishing membrane perturbation from more direct protein–ligand interactions 
is an ongoing challenge in chemical biology. Herein, we present one strategy for doing so, using 
dimeric 6-bromo-2-mercaptotryptamine (BrMT) and synthetic analogues. BrMT is a chemically unstable 
marine snail toxin that has unique effects on voltage-gated K+ channel proteins, making it an attractive 
medicinal chemistry lead. BrMT is amphiphilic and perturbs lipid bilayers, raising the question of 
whether its action against K+ channels is merely a manifestation of membrane perturbation. To 
determine whether medicinal chemistry approaches to improve BrMT might be viable, we synthesized 
BrMT and 11 analogues and determined their activities in parallel assays measuring K+ channel activity 
and lipid bilayer properties. Structure–activity relationships were determined for modulation of the Kv1.4 
channel, bilayer partitioning, and bilayer perturbation. Neither membrane partitioning nor bilayer 
perturbation correlates with K+ channel modulation. We conclude that BrMT’s membrane interactions 
are not critical for its inhibition of Kv1.4 activation. Further, we found that alkyl or ether linkages can 
replace the chemically labile disulfide bond in the BrMT pharmacophore, and we identified additional 
regions of the scaffold that are amenable to chemical modification. Our work demonstrates a strategy 
for determining if drugs act by specific interactions or bilayer-dependent mechanisms, and chemically 
stable modulators of Kv1 channels are reported. 
Biological membranes are composites of lipid bilayers and embedded proteins. It has long 
been known that membrane protein function is sensitive to the composition of the host 
bilayer.(1−4) Commonly, drugs that modulate membrane proteins are presumed to target 
proteins, while in fact many act by changing the bulk properties of the host bilayer, thereby 
altering membrane protein conformational equilibria.(5−8) Modulators that act by bilayer 
perturbation promiscuously modulate a broad spectrum of unrelated membrane 
proteins.(6,7,9−15) Upon interpretation of the mechanisms underlying the physiological actions of 
a drug, it thus becomes crucial to determine whether the action of an amphiphilic modulator 
may involve bulk bilayer perturbation, in addition to more specific interactions. 
A prominent example of the importance of understanding drug mechanism involves capsaicin, 
a natural product of chili peppers that stimulates mammalian peripheral neurons to evoke a 
sensation of burning heat. Capsaicin perturbs bilayers and modulates a wide variety of 
membrane proteins, including Na+, K+, and TRP channels. Capsaicin modulates voltage-gated 
Na+ and K+ channels via lipid bilayer perturbation,(5,7) but capsaicin also has a specific receptor 
site on TRPV1.(16) Medicinal chemistry approaches have been successful in generating 
analogues of capsaicin that are selective TRPV1 inhibitors.(17) Similar efforts to selectively 
modulate Na+ or K+ channels with capsaicin analogues would be foolhardy, however, because 
modulation of membrane proteins via bilayer perturbation is fundamentally promiscuous. Thus, 
determining if lipid bilayer perturbation underlies modulation of a target is critical for the 
prediction of undesired effects on other membrane proteins. 
Because lipophilic and amphiphilic drugs, by their chemical nature, partition into membranes 
and perturb the function of transmembrane proteins, it is a significant challenge to determine 
whether bilayer perturbation is the relevant mechanism underlying modulation of any particular 
target protein. To identify whether drugs operate by a bilayer mechanism, we previously 
developed a method of testing modulators for promiscuous activity against multiple unrelated 
classes of membrane proteins.(7) Although this method is effective, it requires significant 
resources and expertise with many membrane protein preparations. Herein, we report a 
greatly simplified strategy for using the structure–activity relationships (SARs) of a modulator 
against a single target of interest, in combination with synthetic membrane assays, to dissect 
the effects of bulk bilayer perturbation from those of direct protein binding. 
The medicinal chemistry target in this study is the natural product ion channel modulator 
dimeric 6-bromo-2-mercaptotryptamine (BrMT, 1a). A component of the defensive mucus of 
the marine snail Calliostoma canaliculatum, it inhibits voltage-gated K+ channels of the Kv1 
and Kv4 subfamilies.(18) BrMT is an allosteric modulator that inhibits channels by slowing the 
voltage activation steps that precede pore opening, without blocking the central channel 
pore.(19,20) Allosteric modulators of Kv channels are valuable not only as research tools but also 
potentially as therapeutics.(21,22) BrMT itself has limited utility because it contains a chemically 
labile disulfide bond that is degraded by light and reducing conditions.(19) BrMT is thus an 
attractive target for medicinal chemistry efforts to improve its stability. 
Several observations suggest that the activity of BrMT against Kv channels may be affected by 
nonspecific membrane partitioning. First, high concentrations of BrMT applied to outside-out 
membrane patches disrupt the patch clamp seal.(19) Second, a series of chimeras between the 
BrMT-sensitive Shaker Kv channel and the insensitive Kv2.1 channel suggest that the region 
imparting sensitivity is in the S1, S2, and/or S3 transmembrane regions of sensitive 
channels.(23) Third, the wash-in and wash-out kinetics of BrMT are multiphasic, suggesting 
slow accumulation of BrMT in the cell membrane during prolonged exposures.(23,24) Together, 
these effects are consistent with BrMT partitioning in and out of cell membranes and acting 
through the membrane to alter channel function. Similar to many other amphiphilic molecules 
that act by bilayer perturbation, the biological effect of BrMT, with its two aminoethyl groups, 
depends on the side of the membrane to which it is applied.(25−28) BrMT slows Kv channel 
voltage activation only when applied from the extracellular side of the membrane,(19) 
suggesting that its two positive charges may prevent it from crossing the membrane entirely. 
Certain Kv modulator peptides from animal venoms partition into, but do not cross, the outer 
leaflet of the plasma membrane bilayer. Many of these peptides bind to the transmembrane 
voltage sensor domains of the channels.(29−31) However, other closely related venom peptides 
modulate ion channels via bilayer perturbation.(32) It remains unclear whether BrMT modulates 
K+ channels by direct channel binding, by perturbing the bilayer in an indirect manner, or a 
combination of both.(33) To elucidate the mode of action of BrMT and potentially improve its 
properties as a lead compound for future mechanistic or therapeutic studies, we synthesized a 
series of analogues, including several with stable disulfide replacements. The resulting SARs 
were assessed separately in membrane partitioning, perturbation, and ion channel assays to 
test whether specific or nonspecific interactions drive K+ channel activities with these bis-indole 
compounds. 
Materials and Methods 
The Supporting Information contains detailed descriptions of the synthesis of all BrMT 
analogues, cell culture, electrophysiology, gramicidin-based fluorescence quench assay, and 
isothermal titration calorimetry. 
 
Results 
Synthesis of Novel BrMT Analogues 
 
To determine the minimal structural features required for modulation of Kv channels with BrMT 
(1a), we designed a flexible synthesis that would enable facile modification of the tryptamine 
scaffold as well as the disulfide linker (Scheme 1). Our synthetic route is similar to that 
reported by Gallin and Hall.(34) 6-Bromotryptamine (4) was prepared from 6-bromoindole 
according to the sequence reported by Davidson.(35) Protonation of 4 with trichloroacetic acid, 
followed by reaction with freshly distilled S2Cl2,(36,37) yielded a mixture of mono-, di-, and 
trisulfides 1a–c that was characterized by LC-MS. Using a protocol reported by Showalter for 
the preparation of bisindole diselenides as tyrosine kinase inhibitors,(38) we increased the yield 
of the desired disulfide product 1a by treating the mixture with sodium borohydride to reduce 
the di- and trisulfides. Extraction of the nonpolar monosulfide 1c with ether from the basic 
aqueous solution of the resulting indole-2-thiolate, followed by oxidation of the thiolate with 
hydrogen peroxide, gave the disulfide 1a, which was purified by semipreparative HPLC and 
treated with HCl in dioxane to yield the bis-hydrochloride salt. Five different tryptamines were 
prepared via variations of literature protocols (see the Supporting Information for details), and 
these were transformed into the analogous bistryptamine-disulfides 5–8 (Table 1) according to 
the sequence of reactions in Scheme 1. 
 
Scheme 1. Total Synthesis of BrMT 
  
Table 1. Compilation of Properties of BrMT Derivatives 
 
aCalculated as the best fit for inhibition of Kv1.4 ± standard deviation of the parameter fit. 
bCalculated using ChemAxon MarvinSketch version 17.4.3.0. 
cKPW→L is the equilibrium constant for partitioning from water to lipid. Calculated as the geometric mean 
± positive standard error. 
dGramicidin A (gA) channel activity, as measured by the rate of quenching of intravesicular ANTS 
fluorescence by Tl+. gA2 fits are shown in Supporting Information Figure S2. 
eIndicates IC50 or gA2 was not measured (highest concentration tested in parentheses). 
 
The relative instability of bistryptamine-disulfides, and their potential for disulfide exchange 
reactions in vivo,(39) inspired us to explore the use of alternative linkers between the indole 
moieties. Several two-carbon indole linkers have been reported in the literature,(40,41) but we 
expected that these would be too rigid and/or short to be effective disulfide replacements. 
Accordingly, we pursued a convergent synthesis of symmetrical bis-indoles by reacting 
suitable aniline derivatives with bis-alkynes. Dipropargyl ether was selected as our first choice, 
as it could provide a three-atom, ether-based linker between the two indole rings that would 
provide a distance between indole moieties comparable to that of the disulfide linker. 
The optimized synthesis of the ether-linked compounds is given in Scheme 2. Commercially 
available 4-bromo-2-nitroaniline was subjected to a Sandmeyer reaction(42) to yield aryl iodide 
9d in 94% yield. The nitro group of 9d was reduced to aniline 9a using SnCl2 and concentrated 
HCl, followed by N-acylation with acetic anhydride to provide the amide 9c. Amide 9c was 
subjected to the double Sonogashira cross coupling conditions (Table S1, entry 7) to yield the 
bis-alkyne 10c in 90% yield. Treatment of 10c with aqueous TBAF followed by amide 
hydrolysis gave 11 (see SI for details). Alkylation of the bis-indole 11 with Eschenmosher’s 
salt(43) gave the bis-gramine 12 in excellent yield. Owing to the potential instability of 12, it was 
converted without purification to bis-nitrile 13 upon treatment with excess iodomethane and 
sodium cyanide in DMF. Reduction of the nitrile groups in 13 with LiAlH4 was problematic and 
led to partial reduction of the aryl bromide, but reduction of 13 with alane(44) proceeded 
smoothly to give the bis-amine 14 (termed BrET) in 45% yield. Acetylation of 14 with acetic 
anhydride furnished the bis-amide 15 in 60% yield. The related BrMT analogues 16–19 (Table 
1) were prepared by a sequence of reactions similar to those depicted in Scheme 2. Initial 
attempts to reduce 19 to the corresponding diamine were unsuccessful in generating a 
compound of acceptable purity. 
 
Scheme 2. Synthesis of Ether-Linker Analogues 14 (BrET) and 15 
BrMT Derivatization Alters the Potency of Ion Channel Modulation 
 
We assessed the modulatory effects of BrMT analogues on currents through voltage-gated 
potassium channels. To measure the dose–response relations of many compounds in parallel, 
we developed an automated whole-cell voltage clamp assay against a BrMT-sensitive ion 
channel. BrMT inhibits Kv1 (Shaker-type) channels from invertebrates and vertebrates.(18) 
Among members of the Kv1 family, Kv1.4 was chosen because it is a potential target for 
chronic pain and lacks high-affinity modulators.(45−48) Moreover, Kv1.4 is transported efficiently 
and reliably to the plasma membrane in mammalian cell lines, making it optimal for automated 
electrophysiology.(49,50) We therefore created a CHO-K1 cell line with a tetracycline-inducible 
expression of Kv1.4 to provide a scalable cell culture with consistent current levels amenable 
to automated patch clamp methods. 
Amphiphilic drugs often have variable potencies in different experimental preparations. This 
preparation-dependent variability may stem from membrane partitioning that is sensitive to the 
exact composition of the cell membrane, solution flow, and other factors.(24,51,52) Not 
surprisingly, BrMT has different potencies against Shaker Kv1 channels in patches and whole-
cell voltage clamp of HEK cells, CHO cells, and Xenopus oocytes.(23) To serially compare the 
effects of BrMT derivatives with minimal variability, the assays were conducted with a 
commercially available automated patch clamp system that applied consistent solution flow for 
different experiments. 
When BrMT was applied to voltage-clamped cells expressing Kv1.4, it inhibited the currents by 
slowing gating kinetics and reducing peak currents (Figure 1A). The effects of BrMT on kinetics 
were quantified by fitting a double exponential to the rise and decay of the current after a 
depolarizing voltage step (Figure 1B). Increasing concentrations of BrMT progressively slowed 
the gating kinetics (Figure 1C). These effects are similar to those seen with Shaker Kv1 
channels.(19) BrMT has two phenomenological effects on Kv1 channels: a slowing of activation 
kinetics and a diminishment of peak current amplitude after a voltage step.(19) Peak current 
amplitudes of Kv1.4 are affected more dramatically than the rate of channel activation by BrMT 
(Figures 1, 2A). This greater sensitivity of the peak amplitudes may be due to a stronger 
coupling between activation and inactivation in Kv1.4 as compared to Shaker channels.(53) For 
comparison among the BrMT analogues, we therefore used the IC50 values determined from 
the changes in peak current because their fitting was better constrained than the results 
obtained from the more complex curve fitting procedures needed to analyze the activation 
kinetics. Modulation of Kv1.4 currents is apparent over a range of concentrations (Figure S1), 
and IC50 estimates were successfully obtained for most BrMT analogues (Figure 2). The Hill 
slopes deduced from these fits are between 1 and 2 for most analogues. Hill slopes greater 
than 1 could arise from cooperative interactions of the BrMT analogue with multiple subunits of 
Kv channels.(20) One analogue, 15, has a lower Hill slope, which could indicate that this weakly 
modulating analogue acts by a different mechanism, but its low potency precludes any 
significant interpretations. 
 
Figure 1. BrMT inhibits Kv1.4 channel activation. (A) Kv1.4 current responses to indicated BrMT 
concentrations during voltage steps from −100 to 0 mV. (B) Kv1.4 current responses. Colored lines 
correspond to the same BrMT concentrations as in panel A. Stippled lines are fits of eq 2, in the 
Supporting Information. Voltage steps from −100 to 0 mV. Vehicle τact = 1.72 ± 0.02, τinact = 67.3 ± 0.2; 
1.5 μM τact = 2.54 ± 0.02, τinact = 136.6 ± 0.6; 3 μM τact = 3.17 ± 0.03, τinact = 181 ± 2; 6 μM τact = 4.2 ± 
0.4, τinact = 300 ± 20. (C) Time constants of activation (filled circles) and inactivation (empty circles). 
Error bars indicate SEM (n = 9). Stippled lines are fits for Kd, as in ref (19).Kd from τact = 2.9 ± 1.0 μM, 
and Kd from τinact = 1.6 ± 0.7 μM. 
 
Figure 2. Structure–activity relationship of Kv1.4 inhibition. Average inhibition of peak Kv1.4 currents as 
a function of concentration. The shapes and colors of markers correspond to compounds with 
modifications indicated by shapes in the left column. Error bars indicate SEM. Lines are fits of eq 1, in 
the Supporting Ingormation, with parameter values indicated in Table 1. The color and pattern of lines 
correspond to compounds with modifications indicated by the shapes in the left column. (A) BrMT and 
analogues with modifications at the 6-positions on the indole rings. (B) Analogues with modifications of 
the disulfide linker and amines. (C) Ineffective analogues without aminoethyl groups. 
Factors affecting channel inhibition emerge from analysis of SAR data. Replacement of the 6-
bromo moiety of BrMT with a chloro or methyl group as in 5 and 7 had little effect on inhibitor 
potency, whereas substitution with the smaller and more electronegative fluoro group as in 6 
led to a decrease in potency by an order of magnitude (IC50 = 26 μM). Prior measurements 
with a BrMT analogue containing only a hydride at position 6 indicated that it was also an order 
of magnitude less potent than BrMT against Shaker K+ channels.(54) Moving the bromo group 
to the 5-position on the indole ring as in 8 had only a minor effect on potency. These results 
suggest that variable indole substituents are tolerated. 
BrMT loses its potency against Kv channels when the disulfide is reduced to form monomeric 
compounds.(19) On the other hand, the disulfide linkage between the indole groups is 
remarkably tolerant to replacement. For example, activity is retained when the disulfide moiety 
in BrMT is replaced with the ether linkage in 14 or when the disulfide in the 6-chloro-
substituted analogue 5 is replaced with the trimethylene linker in 16. The idea that alterations 
in the linker between the indoles have only mild effects on Kv potency was also reported by 
Gallin and Hall,(34) who found that Kv1 channel inhibition was maintained for 1a–c, wherein the 
number of sulfur atoms bridging the indole rings was varied from one to three. 
The discovery that Kv inhibition is retained with an ether or alkyl linkage between the indole 
rings permitted additional SAR studies using these more chemically stable scaffolds. We found 
that compounds 11, 18, and 19, which each lack the aminoethyl side chain, are inactive at the 
highest concentrations tested. Moreover, the N-acetyl derivative 15 and the N,N-
dimethylaminoethyl analogue 17 are less potent than the parent compound BrET (14) by more 
than an order of magnitude. Collectively, these results indicate that modification at the 2- and 
6-positions of the indole rings of BrMT is well-tolerated, but the aminoethyl groups at the 3-
positions are critical for channel activity: compounds lacking basic side chains at the 3-position 
were inactive (e.g., 11, 18, and 19). 
BrMT Derivatization Alters Bilayer Partitioning, but Partitioning Does Not Predict 
Ion Channel Modulation 
 
We measured the degree to which the BrMT analogues partition into membranes using 
isothermal titration calorimetry (ITC).(55) These experiments were conducted with suspensions 
of large unilamellar phospholipid vesicles (LUVs) (see SI) as a surrogate for the bilayer 
component of cell membranes. All of the analogues partitioned into the bilayer with water → 
bilayer partition coefficients (KPW→L) ranging between 450 and 3900 (Table 1); the calculated 
log([n-octanol]/[water]) (ClogP) values are also listed for comparison. KPW→L values increased 
when the disulfide linkage was replaced with a three-atom alkyl or an ether linkage. For 
example, replacing the disulfide linkage of BrMT (1a) (KPW→L = 560) with an ether linkage as in 
14 (KPW→L = 3100) led to an increase in KPW→L values, as did replacing the disulfide bridge of 
the chloro analogue 5 (KPW→L = 1000) with a trimethylene linkage in 16 (KPW→L = 3300). If 
channel modulation results from compounds partitioning into the membrane bilayer, we would 
expect that the Kv1.4 IC50 values would correlate with the KPW→L values, but this is not the 
case (Figure 3). Examination of small structural changes that influence partitioning and/or 
channel modulation also indicates that the two properties are independent. Replacing the 
disulfide linkage of BrMT (1a) with the ether moiety in 14 increases KPW→L values but has little 
impact on IC50. The acetylated, nonbasic compound 15 has an increased fraction in 
membranes vs its basic parent 14 (KPW→L = 3900 vs 3100), but its potency against Kv1.4 drops 
substantially (IC50 = 70 μM vs 2.7 μM) (Figure 3, brown arrows). Replacing the disulfide linkage 
of 5 with a trimethylene linkage in 16 also increases KPW→L values with little impact on IC50. 
Comparison of 16 to the related N,N-dimethylaminomethyl compound 17 shows a rare 
example of a relatively minor structural change that simultaneously decreases both the KPW→L 
values and inhibitory potency (Figure 3, green arrows). Overall, increases in the partition 
coefficient were not coupled to an increase of inhibitory potency. Fitting a linear regression to 
KPW→L and IC50 values did not yield any significance (r = 0.34, p = 0.37). The fraction of a BrMT 
analogue in the bilayer does not correlate with its potency, which suggests that bilayer 
partitioning is not sufficient for Kv channel modulation. 
 
Figure 3. Membrane partition coefficients do not predict channel inhibition. Numbers by each marker 
denote the analogue identity. The shape and color of markers correspond to Figure 2. Values are from 
Table 1. Black arrows denote analogues with such a low activity that we could not measure it (null 
response), with the marker indicating the highest concentration tested. Brown and green arrows with 
dashed lines indicate modification of the disulfide linker. Brown and green arrows with dotted lines 
indicate modification of aminoethyl groups. 
Membrane Perturbation by BrMT Derivatives Is Not Correlated with Bilayer 
Partitioning 
 
Bilayer partitioning itself did not underlie the variable potencies of Kv channel inhibitors, but it 
remains a possibility that nonspecific bilayer perturbation might affect their inhibition of Kv1.4 
because small membrane-perturbing amphiphiles are known to inhibit many Kv channels.(7) 
We therefore probed for bilayer-modifying effects using a gramicidin A (gA)-based 
fluorescence assay that monitors changes of gA activity in LUVs.(56,57) This assay exploits the 
gramicidin channel-permeant thallous ion (Tl+), which quenches the fluorescence of the water-
soluble fluorophore 8-aminonaphthalene-1,3,6-trisulfonate (ANTS). gA permits transmembrane 
Tl+ flux only as a dimer, and the equilibrium between monomeric and dimeric gA is altered by 
lipid bilayer perturbation. ANTS fluorescence is measured after addition of Tl+ to a suspension 
of ANTS-loaded gA-containing LUVs, and the time course of fluorescence quenching (Figure 
4A) provides a measure of the changes in intravesicular [Tl+]. The initial rate of fluorescence 
quenching provides a measure of the initial rate of Tl+ influx into the LUVs,(58−60) which varies 
with changes in the number of dimeric gA molecules in the LUV membrane. It is thus possible 
to determine how a drug, or other amphiphile, shifts the gA monomer/dimer equilibrium, which 
provides a measure of the bilayer-modifying potency of the molecule of interest. The BrMT 
analogue concentration that elicits a doubling of the rate of gA-dependent quenching is 
denoted as gA2 and serves as a metric for the bilayer-perturbing potency (Figure S2). Note 
that a lower gA2 concentration indicates more potent bilayer perturbation. Some noticeable 
structural trends were observed (Table 1). Analogues 11 and 18 that lack aminoethyl side 
chains did not have a measurable gA2 because they caused no changes in the quench rate at 
the highest concentration tested. This result indicates that these analogues have minimal 
effects on bilayer properties. The linkage between the tryptamine monomers also affected 
bilayer perturbation. For example, the ether-linked derivatives 14 and 15 had the lowest gA2, 
and replacing the disulfide linkage of 5 with a trimethylene chain as in 16 did not detectably 
change gA2. Other changes to the aminoethyl side chains as shown by 14 vs 15 and 16 vs 17 
increased the bilayer-modifying potency. 
 
Figure 4. Membrane perturbation is distinct from partitioning and does not predict channel inhibition. (A) 
Gramicidin A (gA) channel activity, as measured by the rate of quenching of intravesicular ANTS 
fluorescence by Tl+. For each trace, the gray dots denote the results obtained in the nine individual 
repeats, whereas the colored dots denote the average value at each time point. (B) Membrane 
partition–perturbation relationships. Numbers next to the different markers denote the analogue’s 
identity. The shape and color of markers are as in Figure 2. Data from Table 1. Black arrows indicate a 
null response, with the marker indicating the highest concentration tested. Brown and green arrows with 
dashed lines indicate modification of the disulfide linker. Brown and green arrows with dotted lines 
indicate modification of aminoethyl groups. (C) Membrane perturbation–inhibition relationship (data 
from Table 1). 
Bilayer partitioning did not predict the bilayer-perturbing potency, as there was no obvious 
correlation between KPW→L and gA2 (Figure 4B) (r = −0.27, p = 0.47). Divergent effects of 
structure on KPW→L and gA2 can also be seen when comparing the related analogues 1a vs 14 
and 15, as well as 5 vs 16 and 17. For compounds 1a, 14, and 15, a decreasing gA2 was 
consistent with an increasing KPW→L, as would be expected if an increase in the partition 
coefficient decreased the aqueous concentration needed to reach a mole fraction in the bilayer 
that caused the perturbation. Substituting an ether linkage into 1a giving 14, for example, 
increased bilayer partitioning and perturbation. When the aminoethyl groups in 14 are 
acetylated to give 15, there is a further slight increase of bilayer partitioning and perturbation 
(Figure 4B, brown arrows). However, in a sequence of modifications at the same positions of 
the Cl-substituted disulfide in the series 5, 16, and 17, gA2 appeared insensitive to KPW→L (5 → 
16, Figure 4B, stippled green arrows) and then anticorrelated (16 → 17). A particularly striking 
example of the divergence between gA2 and KPW→L is seen when the bromo group at C6 in 1a 
is moved to C5 in 8, resulting in a moderate increase in KPW→L yet complete inactivity in the gA 
assay (Figure 4A, right panel). Overall, BrMT analogues did not show a consistent 
dependence of bilayer perturbation on partitioning. 
Potency of Channel Modulation Is Not Dictated by Bilayer Perturbation 
 
Bilayer perturbation was altered by BrMT analogues in a fashion distinct from partitioning, so 
we then assessed whether perturbation might be the mechanism underlying Kv modulation. 
When Kv1.4 IC50 values are plotted vs gA2 values as a measure of bilayer perturbation, there 
is no obvious correlation (r = −0.37, p = 0.36) (Figure 4C). In fact, more potent bilayer-
perturbing compounds are generally weaker inhibitors of Kv1.4. Substitution of the native 
disulfide linkage of 1a for the ether linker in 14 led to a 10-fold decrease in gA2 (10-fold 
increase in bilayer-perturbing potency) with a slight decrease in potency of channel inhibition 
(IC50 = 2.7 μM for 14 vs 1.1 μM for 1a). In contrast, when the disulfide linkage in the 6-chloro 
analogue 5 is replaced with the trimethylene linker in 16, there is little change in gA2, but there 
is a 3-fold increase in IC50. Changes to the aminoethyl side chain (e.g., 14 → 15 or 16 → 17) 
decrease gA2 but increase IC50 (Figure 4C). Notably, analogue 8, which does not perturb 
bilayers at the highest concentration tested, is a strong modulator of Kv1.4, whereas the most 
bilayer-perturbing analogue 15 is a weak modulator of Kv1.4 channels. Inspection of the 
current traces recorded in the presence of 15 reveals that inactivation is accelerated. This 
action is consistent with prior findings that bilayer-perturbing detergents modulate inactivation 
of Kv1 channels(61) and suggests that Kv1.4 modulation by 15 may occur via a mechanism 
different from that of the less bilayer-perturbing BrMT analogues. 
Discussion 
Overall, these relationships show that Kv1.4 inhibition does not correlate with either bilayer 
partitioning or bilayer perturbation. We conclude that though BrMT and its analogues that are 
active against ion channels all partition into bilayers and usually perturb bilayer properties, the 
partitioning and alterations in bilayer properties do not drive potassium channel modulation. 
We conclude that specific interactions between Kv1.4 and “strong” modulators such as BrMT 
and BrET are critical for activity. 
Limitations 
Our results show that bilayer partitioning and perturbation are not critical determinants of 
modulation of Kv channels by BrMT or its analogues. These conclusions rely on interpretations 
that have caveats: 
1. The bilayer partitioning and perturbation experiments were conducted with bilayers 
formed by synthetic phosphocholine lipids. Results in multicomponent bilayers,(62−64) 
and whole cells,(10) have been found to be similar to those obtained in single-component 
bilayers. On the basis of these previous validations, we expect the impact of 
compounds on single-component bilayers will extend to living cells more generally. 
However, our experiments do not exclude the possibility that BrMT derivatives partition 
differently into CHO cells and/or interact in a binding pocket with specialized lipids. 
2. Our interpretation assumes that the BrMT derivatives alter Tl+ flux through gA 
channels by perturbing lipid membranes, not by interacting directly with the gA channel 
itself. Our experiments cannot completely exclude such direct effects; results with many 
different structurally diverse amphiphiles show that they have similar effects on right- 
and left-handed channels, which effectively excludes direct interactions.(6,8,65) The 
achirality of the BrMT derivatives here precludes such a validation. 
Implications 
 
By using a series of analogues of the snail defensive toxin BrMT, we identified certain 
molecular features that determine its inhibition of potassium channels as well as its partitioning 
into and perturbation of membranes. Our findings are consistent with BrMT acting through a 
drug binding pocket at the lipid bilayer–potassium channel interface.(31,66,67) The positive 
charges of other amphiphilic, membrane partitioning compounds are crucial for their inhibition 
of Kv1 channels,(68) which is consistent with our observations for BrMT and analogues. 
Compounds 1a, 5, 7, 8, 14, and 16 each strongly inhibit Kv channels, but of these only the 
native compound BrMT (1a) has a minimal impact on membranes. The BrMT analogue 7 is the 
only strong Kv1.4 inhibitor that shows a relative decrease in bilayer partitioning and is a more 
potent bilayer perturber. On the other hand, 8 is the only strong Kv1.4 inhibitor that is a less 
potent bilayer perturber and has a partition coefficient higher than that of BrMT. Thus, all of our 
strongly Kv1.4 inhibiting analogues either partitioned into or perturbed the bilayer more than 
BrMT. We speculate that membrane partitioning and perturbation may have played a role in 
the natural selection of BrMT to be the defensive toxin of the sea snail, possibly because of its 
minimal negative impacts on snail membranes. We also conclude that bilayer interactions are 
not correlated with inhibition of Kv1.4. 
BrMT Analogues as Research Tools 
 
The determination of what conformations ion channels adopt is an ongoing challenge of 
molecular physiology. BrMT is a toxin that selectively binds to resting Kv conformations,(19) 
making BrMT a powerful tool to explore conformational changes of potassium channels. 
Conformation-selective ligands are of increasing importance for associating functional states of 
proteins with structurally defined conformations. For example, conformation-selective toxins 
were the enabling factors for reconstructing TRPV1 ion channels in an open state,(16,69−71) and 
co-crystals of ASIC ion channels with peptide toxin gating modifiers led to the identification of 
structures of new channel conformations.(72−74) In functional studies, tagged conformation-
selective toxins allow imaging of Kv2 channels adopting specific conformations in live 
cells.(75,76) BrMT-like compounds similarly can stabilize the resting conformation of Kv1 channel 
voltage sensors, and they have the potential to be useful tools for studying channel 
conformations in cells and live tissue. The ether-linked analogue BrET (14) identified in this 
study is comparable in potency to BrMT but lacks the unstable disulfide moiety of the natural 
product. With the information that modifications to the indole ring and the linker between them 
are well-tolerated, a path is revealed for generating additional conformation-selective ligands 
targeting resting conformations of Kv1 ion channel voltage sensors. 
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gA2 concentration of compound that elicits a doubling of the rate of gA-dependent 
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HPW→L enthalpy of partitioning from water into lipid 
IC50 half-maximal inhibitory concentration 
ITC isothermal calorimetry 
KPW→L equilibrium constant for partitioning from water into lipid 
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